Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.03
Delayed Data
As of May 27
 +0.01 / +0.98%
Today’s Change
0.64
Today|||52-Week Range
2.10
-26.95%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.02
Today’s open0.90
Day’s range0.90 - 1.03
Volume300
Average volume (3 months)9,210
Market cap$11.5M
Dividend yield--
Data as of 3:42pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...+0.09+2.44%
ATOSAtossa Genetics Inc+0.03+11.55%
MDCLMedicine Man Technol...0.000.00%
CYANCyanotech Corp+0.07+1.41%
Data as of 4:00pm ET, 05/27/2016

Financials

Last reporting dateMarch 17, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers

Search for Jobs